• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

EClinicalMedicine . Dynamic changes of pulmonary diffusion capacity in survivors of non-critical COVID-19 during the first six months

tetano

Editor, Senior Moderator
EClinicalMedicine


. 2022 Jan;43:101255.
doi: 10.1016/j.eclinm.2021.101255. Epub 2022 Jan 6.
Dynamic changes of pulmonary diffusion capacity in survivors of non-critical COVID-19 during the first six months


Mu Chen[SUP] 1 [/SUP], Jingwei Liu[SUP] 2 [/SUP], Ping Peng[SUP] 1 [/SUP], Wenhua Jian[SUP] 2 [/SUP], Yi Gao[SUP] 2 [/SUP], Liman Fang[SUP] 2 3 [/SUP], Yanhui Yu[SUP] 4 [/SUP], Shuxin Zhong[SUP] 2 3 [/SUP], Hui Peng[SUP] 1 [/SUP], Xilong Deng[SUP] 1 [/SUP], Yuqi Zhou[SUP] 5 [/SUP], Sheng Du[SUP] 2 [/SUP], Ruchong Chen[SUP] 2 3 [/SUP], Xiaoneng Mo[SUP] 1 [/SUP], Nanshan Zhong[SUP] 2 6 [/SUP], Shiyue Li[SUP] 2 6 [/SUP]



Affiliations

Abstract

Background: The dynamic trends of pulmonary function in coronavirus disease 2019 (COVID-19) survivors since discharge have been rarely described. We aimed to describe the changes of lung function and identify risk factors for impaired diffusion capacity.
Methods: Non-critical COVID-19 patients admitted to the Guangzhou Eighth People's Hospital, China, were enrolled from March to June 2020. Subjects were prospectively followed up with pulmonary function tests at discharge, three and six months after discharge.
Findings: Eighty-six patients completed diffusion capacity tests at three timepoints. The mean diffusion capacity for carbon monoxide (D[SUB]LCO[/SUB])% pred was 79.8% at discharge and significantly improved to 84.9% at Month-3. The transfer coefficient of the lung for carbon monoxide (K[SUB]CO[/SUB])% pred significantly increased from 91.7% at discharge to 95.7% at Month-3. Both of them showed no further improvement at Month-6. The change rates of D[SUB]LCO[/SUB]% pred and K[SUB]CO[/SUB]% pred were significantly higher in 0-3 months than in 3-6 months. The alveolar ventilation (V[SUB]A[/SUB]) improved continuously during the follow-ups. At Month-6, impaired D[SUB]LCO[/SUB]% pred was associated with being female (OR 5.2 [1.7-15.8]; p = 0.004) and peak total lesion score (TLS) of chest CT > 8.5 (OR 6.6 [1.7-26.5]; p = 0.007). D[SUB]LCO[/SUB]% pred and K[SUB]CO[/SUB]% pred were worse in females at discharge. And in patients with impaired diffusion capacity, females' D[SUB]LCO[/SUB]% pred recovered slower than males.
Interpretation: The first three months is the critical recovery period for diffusion capacity. The impaired diffusion capacity was more severe and recovered slower in females than in males. Early pulmonary rehabilitation and individualized interventions for recovery are worthy of further investigations.

Keywords: COVID-19; Dynamic changes; Pulmonary diffusion capacity.
 
Back
Top Bottom